This Surgical Site Infection Control market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The surgical site infection control market size has grown strongly in recent years. It will grow from $4.74 billion in 2024 to $5 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to growing awareness and emphasis on infection prevention protocols, integration of infection control outcomes into healthcare, growing concerns about antibiotic resistance, the shift towards value-based care models, and stringent implementation of regulatory standards and guidelines.
The surgical site infection control market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to demand for minimally invasive surgical procedures, the aging population, associated higher surgical volumes, increasing preference for single-use infection control products, investments in healthcare infrastructure development, and patient safety initiatives. Major trends in the forecast period include the continued development of advanced sterilization methods and technologies, advancements in surgical techniques, rising trends in outpatient surgeries, single-use and disposable products, and the development of advanced PPE solutions.
The increasing number of surgical procedures is expected to drive the growth of the surgical site infection control market. The rise in surgical procedures is fueled by advancements in medical technology, a growing elderly population, and an increasing prevalence of chronic diseases. Surgical site infection control measures, including sterilization, antibiotic prophylaxis, and aseptic techniques, play a crucial role in preventing infections, reducing complications, and improving patient outcomes. For example, in June 2024, the American Society of Plastic Surgeons reported that the total number of abdominoplasty surgeries performed in the United States increased from 162,002 in 2022 to 170,110 in 2023, reflecting a 5% rise. As a result, the growing number of surgical procedures is driving the demand for surgical site infection control solutions.
Leading companies in the surgical site infection control market are focusing on developing advanced products to stay competitive. One area of innovation is in surgical gowns featuring innovative fabrics, designed to offer enhanced protection and comfort. These gowns utilize advanced materials with improved barrier properties, breathability, and durability. For instance, Invenio Medical Inc. launched the V90 series in March 2022, tailored to meet the rigorous demands of modern healthcare settings while maintaining cost-effectiveness. This series incorporates advanced features aimed at maximizing performance and comfort, reflecting Invenio's commitment to meeting evolving healthcare needs with state-of-the-art technology and practical pricing strategies.
In February 2023, Ansell Limited, an Australian manufacturer, acquired a 50% shareholding in Careplus (M) Sdn Bhd for US$9 million to strengthen its supply chain and production capabilities. Careplus (M) Sdn Bhd, based in Malaysia, specializes in manufacturing surgical, latex, and nitrile powder-free gloves, aligning with Ansell's strategic objectives in the healthcare sector.
Major companies operating in the surgical site infection control market are Johnson and Johnson, Thermo Fisher Scientific Inc., 3M Company, Kimberly-Clark Corporation, Becton Dickinson and Company, Stryker Corporation, Owens & Minor Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc, Terumo Corporation, Smith & Nephew plc, Hartmann Group, ConvaTec Inc., Ansell Limited, Mölnlycke Health Care, Halyard Health Inc., DeRoyal Industries Inc., Excelsior Medical LLC, Xttrium Laboratories Inc., Precept Medical Products Inc., Cantel Medical Corp.
North America was the largest region in the surgical site infection control market in 2024. The regions covered in the surgical site infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical site infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Surgical site infection (SSI) control encompasses a set of practices aimed at preventing infections occurring at or near a surgical incision within 30 days (or up to 90 days for certain surgeries). These practices include maintaining sterile conditions, adhering to proper hand hygiene, administering antibiotic prophylaxis, and ensuring appropriate post-operative wound care. Effective SSI control is crucial for reducing patient morbidity, mortality rates, and healthcare expenditures.
Key product types for surgical site infection control include surgical scrubs, hair clippers, surgical drapes, surgical irrigation systems, skin preparation solutions, medical nonwovens, surgical gloves, manual reprocessor solutions, disinfectants, and other related items. Surgical scrubs are specialized garments worn by surgical personnel to maintain cleanliness and minimize the transmission of microorganisms during procedures. SSIs can manifest as superficial incisional, deep incisional, or organ/space infections, and prevention measures are applied across a range of surgeries such as cesarean sections, gastric bypass, cataract surgery, dental procedures, and more. These products are utilized by hospitals, ambulatory surgical centers, and other healthcare facilities.
The surgical site infection control market research report is one of a series of new reports that provides surgical site infection control market statistics, including surgical site infection control industry global market size, regional shares, competitors with a surgical site infection control market share, detailed surgical site infection control market segments, market trends and opportunities, and any further data you may need to thrive in the surgical site infection control industry. This surgical site infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The surgical site infection control market consists of sales of sterile surgical gloves and instruments, antiseptic skin preparation solutions, and post-operative dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The surgical site infection control market size has grown strongly in recent years. It will grow from $4.74 billion in 2024 to $5 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to growing awareness and emphasis on infection prevention protocols, integration of infection control outcomes into healthcare, growing concerns about antibiotic resistance, the shift towards value-based care models, and stringent implementation of regulatory standards and guidelines.
The surgical site infection control market size is expected to see strong growth in the next few years. It will grow to $6.1 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to demand for minimally invasive surgical procedures, the aging population, associated higher surgical volumes, increasing preference for single-use infection control products, investments in healthcare infrastructure development, and patient safety initiatives. Major trends in the forecast period include the continued development of advanced sterilization methods and technologies, advancements in surgical techniques, rising trends in outpatient surgeries, single-use and disposable products, and the development of advanced PPE solutions.
The increasing number of surgical procedures is expected to drive the growth of the surgical site infection control market. The rise in surgical procedures is fueled by advancements in medical technology, a growing elderly population, and an increasing prevalence of chronic diseases. Surgical site infection control measures, including sterilization, antibiotic prophylaxis, and aseptic techniques, play a crucial role in preventing infections, reducing complications, and improving patient outcomes. For example, in June 2024, the American Society of Plastic Surgeons reported that the total number of abdominoplasty surgeries performed in the United States increased from 162,002 in 2022 to 170,110 in 2023, reflecting a 5% rise. As a result, the growing number of surgical procedures is driving the demand for surgical site infection control solutions.
Leading companies in the surgical site infection control market are focusing on developing advanced products to stay competitive. One area of innovation is in surgical gowns featuring innovative fabrics, designed to offer enhanced protection and comfort. These gowns utilize advanced materials with improved barrier properties, breathability, and durability. For instance, Invenio Medical Inc. launched the V90 series in March 2022, tailored to meet the rigorous demands of modern healthcare settings while maintaining cost-effectiveness. This series incorporates advanced features aimed at maximizing performance and comfort, reflecting Invenio's commitment to meeting evolving healthcare needs with state-of-the-art technology and practical pricing strategies.
In February 2023, Ansell Limited, an Australian manufacturer, acquired a 50% shareholding in Careplus (M) Sdn Bhd for US$9 million to strengthen its supply chain and production capabilities. Careplus (M) Sdn Bhd, based in Malaysia, specializes in manufacturing surgical, latex, and nitrile powder-free gloves, aligning with Ansell's strategic objectives in the healthcare sector.
Major companies operating in the surgical site infection control market are Johnson and Johnson, Thermo Fisher Scientific Inc., 3M Company, Kimberly-Clark Corporation, Becton Dickinson and Company, Stryker Corporation, Owens & Minor Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc, Terumo Corporation, Smith & Nephew plc, Hartmann Group, ConvaTec Inc., Ansell Limited, Mölnlycke Health Care, Halyard Health Inc., DeRoyal Industries Inc., Excelsior Medical LLC, Xttrium Laboratories Inc., Precept Medical Products Inc., Cantel Medical Corp.
North America was the largest region in the surgical site infection control market in 2024. The regions covered in the surgical site infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical site infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Surgical site infection (SSI) control encompasses a set of practices aimed at preventing infections occurring at or near a surgical incision within 30 days (or up to 90 days for certain surgeries). These practices include maintaining sterile conditions, adhering to proper hand hygiene, administering antibiotic prophylaxis, and ensuring appropriate post-operative wound care. Effective SSI control is crucial for reducing patient morbidity, mortality rates, and healthcare expenditures.
Key product types for surgical site infection control include surgical scrubs, hair clippers, surgical drapes, surgical irrigation systems, skin preparation solutions, medical nonwovens, surgical gloves, manual reprocessor solutions, disinfectants, and other related items. Surgical scrubs are specialized garments worn by surgical personnel to maintain cleanliness and minimize the transmission of microorganisms during procedures. SSIs can manifest as superficial incisional, deep incisional, or organ/space infections, and prevention measures are applied across a range of surgeries such as cesarean sections, gastric bypass, cataract surgery, dental procedures, and more. These products are utilized by hospitals, ambulatory surgical centers, and other healthcare facilities.
The surgical site infection control market research report is one of a series of new reports that provides surgical site infection control market statistics, including surgical site infection control industry global market size, regional shares, competitors with a surgical site infection control market share, detailed surgical site infection control market segments, market trends and opportunities, and any further data you may need to thrive in the surgical site infection control industry. This surgical site infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The surgical site infection control market consists of sales of sterile surgical gloves and instruments, antiseptic skin preparation solutions, and post-operative dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Surgical Site Infection Control Market Characteristics3. Surgical Site Infection Control Market Trends and Strategies4. Surgical Site Infection Control Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Surgical Site Infection Control Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Surgical Site Infection Control Market34. Recent Developments in the Surgical Site Infection Control Market
5. Global Surgical Site Infection Control Growth Analysis and Strategic Analysis Framework
6. Surgical Site Infection Control Market Segmentation
7. Surgical Site Infection Control Market Regional and Country Analysis
8. Asia-Pacific Surgical Site Infection Control Market
9. China Surgical Site Infection Control Market
10. India Surgical Site Infection Control Market
11. Japan Surgical Site Infection Control Market
12. Australia Surgical Site Infection Control Market
13. Indonesia Surgical Site Infection Control Market
14. South Korea Surgical Site Infection Control Market
15. Western Europe Surgical Site Infection Control Market
16. UK Surgical Site Infection Control Market
17. Germany Surgical Site Infection Control Market
18. France Surgical Site Infection Control Market
19. Italy Surgical Site Infection Control Market
20. Spain Surgical Site Infection Control Market
21. Eastern Europe Surgical Site Infection Control Market
22. Russia Surgical Site Infection Control Market
23. North America Surgical Site Infection Control Market
24. USA Surgical Site Infection Control Market
25. Canada Surgical Site Infection Control Market
26. South America Surgical Site Infection Control Market
27. Brazil Surgical Site Infection Control Market
28. Middle East Surgical Site Infection Control Market
29. Africa Surgical Site Infection Control Market
30. Surgical Site Infection Control Market Competitive Landscape and Company Profiles
31. Surgical Site Infection Control Market Other Major and Innovative Companies
35. Surgical Site Infection Control Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Surgical Site Infection Control Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on surgical site infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for surgical site infection control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The surgical site infection control market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Surgical Scrubs; Hair Clippers; Surgical Drapes; Surgical Irrigation; Skin Preparation Solution; Medical Nonwovens; Surgical Gloves; Manual Reprocessor Solution; Disinfectants; Other Products2) By Type of Infection: Superficial Incisional Surgical Site Infection (SSI); Deep Incisional Surgical Site Infection (SSI); Organ or Space Surgical Site Infection (SSI)
3) By Surgery Type: Cesarean Section; Gastric Bypass; Cataract Surgery; Dental Restoration; Other Surgery Types
4) By End-user: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Surgical Scrubs: Antimicrobial Surgical Scrubs; Non-Antimicrobial Surgical Scrubs2) By Hair Clippers: Corded Hair Clippers; Cordless Hair Clippers
3) By Surgical Drapes: Sterile Surgical Drapes; Disposable Surgical Drapes; Reusable Surgical Drapes
4) By Surgical Irrigation: Sterile Irrigation Fluids; Antiseptic Irrigation Solutions; Non-Antiseptic Irrigation Solutions
5) By Skin Preparation Solution: Alcohol-Based Skin Preparations; Chlorhexidine-Based Skin Preparations; Povidone-Iodine-Based Skin Preparations
6) By Medical Nonwovens: Surgical Gowns; Surgical Masks; Sterile Sponges and Pads
7) By Surgical Gloves: Latex Surgical Gloves; Nitrile Surgical Gloves; Vinyl Surgical Gloves; Powdered Surgical Gloves; Powder-Free Surgical Gloves
8) By Manual Reprocessor Solution: Enzyme-Based Reprocessing Solutions; Chemical-Based Reprocessing Solutions
9) By Disinfectants: Alcohol-Based Disinfectants; Chlorine-Based Disinfectants; Hydrogen Peroxide-Based Disinfectants
10) By Other Products: Wound Care Products; Sterilization Equipment; Antiseptic Towelettes
Key Companies Mentioned: Johnson and Johnson; Thermo Fisher Scientific Inc.; 3M Company; Kimberly-Clark Corporation; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Surgical Site Infection Control market report include:- Johnson and Johnson
- Thermo Fisher Scientific Inc.
- 3M Company
- Kimberly-Clark Corporation
- Becton Dickinson and Company
- Stryker Corporation
- Owens & Minor Inc.
- B. Braun Melsungen AG
- Zimmer Biomet Holdings Inc
- Terumo Corporation
- Smith & Nephew plc
- Hartmann Group
- ConvaTec Inc.
- Ansell Limited
- Mölnlycke Health Care
- Halyard Health Inc.
- DeRoyal Industries Inc.
- Excelsior Medical LLC
- Xttrium Laboratories Inc.
- Precept Medical Products Inc.
- Cantel Medical Corp.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | April 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 5 Billion |
Forecasted Market Value ( USD | $ 6.1 Billion |
Compound Annual Growth Rate | 5.1% |
Regions Covered | Global |
No. of Companies Mentioned | 22 |